<DOC>
	<DOCNO>NCT02862639</DOCNO>
	<brief_summary>The current management osteoarthritis base non-pharmacological pharmacological mean include intra-articular injection . The recommendation management hip osteoarthritis stipulate intra-articular injection corticosteroid may consider patient exacerbation respond oral treatment . Several recent study show effectiveness intra-articular corticosteroid compare anesthetic . The intra-articular injection viscosupplementation alone never validate indication since control study show efficacy placebo . At present , viscosupplementation consider anti-osteoarthritic symptomatic slow-acting interest yet establish hip osteoarthritis .</brief_summary>
	<brief_title>Efficacy Viscosupplementation Associated With Intra-articular Corticosteroid Injection Versus Intra-articular Injection Corticosteroids Alone Osteoarthritis Hip</brief_title>
	<detailed_description>Show superiority intra-articular injection viscosupplementation combination corticosteroid compare intra-articular injection corticosteroid alone treatment hip osteoarthritis .</detailed_description>
	<mesh_term>Osteoarthritis</mesh_term>
	<mesh_term>Osteoarthritis , Hip</mesh_term>
	<criteria>patient hip osteoarthrosis ( stage II et III accord Kellgren et Lawrence ) walk alone patient patient consent participate study patient enrol national healthcare insurance program patient old 18 year Patients hip osteoarthrosis ( stage I et IV accord Kellgren et Lawrence ) patient rapidly destructive hip osteoarthritis patient inflammatory rheumatism patient microcrystalline arthritis patient hip osteonecrosis patient receive corticosteroid previous three month patient receive intra articular injection viscosupplementation previous six month patient haemostatic disorder patient consumption painkiller tier 3</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2016</verification_date>
</DOC>